Abbott Announces R&D Investment in Clonmel for Continued Development of Cardiovascular Devices

We would like to extend our congratulations to IEA Member Abbott on their recent announcement of their investment plans for their vascular devices site in Clonmel, Co. Tipperary.

Over the next three years, Abbott will invest €37.8 million in an R&D programme focusing on the discovery, innovation and development of a number of projects, including next generation drug eluting stents, as well as coronary and endovascular balloon technologies.

Read more about the announcement via RTE News here.